Sodium Chloride Injection

DRUG12 trials

Conditions

AnalgesiaBlockChronic Low-back PainDelirium in Old AgeDermatitis, AtopicDexmedetomidineFascia Iliaca BlockGait, Hemiplegic

Phase 1

Evaluate the Safety, Tolerability of BAT6026

Active, not recruitingNCT06094179

Bio-Thera SolutionsDermatitis, Atopic

Start: 2023-11-09End: 2026-06-30Target: 33Updated: 2026-02-10

Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery

RecruitingNCT06614010

Qianfoshan HospitalDexmedetomidine, Fascia Iliaca Block

Start: 2023-02-05End: 2025-12-01Target: 207Updated: 2024-09-26

Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years

Active, not recruitingNCT06675032

Shanghai Reinovax Biologics Co.,LTDPneumococcal Infectious Disease

Start: 2024-04-27End: 2026-03-31Target: 230Updated: 2025-12-26

A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects

RecruitingNCT06760455

Chengdu Brilliant Pharmaceutical Co., Ltd.Healthy Participants

Start: 2025-01-10End: 2026-12-05Target: 48Updated: 2025-02-12

Phase 2

Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis

NCT05912946

West China HospitalInterstitial Cystitis

Start: 2023-10-15End: 2024-10-15Target: 129Updated: 2023-09-15

Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain

RecruitingNCT06471998

GCS Ramsay Santé pour l'Enseignement et la RechercheChronic Low-back Pain

Start: 2025-02-28End: 2025-09-30Target: 29Updated: 2025-03-27

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

RecruitingNCT07100418

Fujian Shengdi Pharmaceutical Co., Ltd.Hyperlipidemia

Start: 2025-08-12End: 2027-01-31Target: 200Updated: 2025-09-10

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

RecruitingNCT07297797

Fujian Shengdi Pharmaceutical Co., Ltd.Mild to Moderate Hypertension

Start: 2026-01-14End: 2027-10-01Target: 234Updated: 2026-01-26

Phase 3

Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery

CompletedNCT06904248

Yangtze River Pharmaceutical Group Co., Ltd.Participants With Acute Moderate to Severe Pain Following Abdominal Surgery

Start: 2024-01-29End: 2025-02-10Updated: 2025-04-01

Phase 4

Comparison of Two Analgesic Strategies After Scheduled Caesarean

CompletedNCT04755712

GCS Ramsay Santé pour l'Enseignement et la RechercheAnalgesia

Start: 2021-03-22End: 2022-10-12Updated: 2024-08-05

Unknown Phase

A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

RecruitingNCT05242419

Second Affiliated Hospital of Wenzhou Medical UniversityDelirium in Old Age, Injection, Non-cardiac Surgery +1

Start: 2022-06-10End: 2025-12-30Target: 40Updated: 2025-04-02

Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait

NCT05519592

Henri Mondor University HospitalBlock, Gait, Hemiplegic, Neurologic Disorder +1

Start: 2022-09-09End: 2023-10-30Target: 30Updated: 2022-08-29

Related Papers

Posterior quadratus lumborum block versus intrathecal morphine analgesia after scheduled cesarean section: a prospective, randomized, controlled study.

2026-01-054 citations

Abstract 4365285: A Phase I, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of N-acetylgalactosamine Small Interfering RNA Conjugate, BPR-30221616, in Healthy Participants, for Potential Treatment of Transthyretin Amyloidosis

Circulation2025-11-03

Intravesical Interferon Therapy vs Hyaluronic Acid for Pain Among Female Individuals With Interstitial Cystitis

JAMA Network Open2024-04-0813 citations